Verubulin

CAS No. 827031-83-4

Verubulin( —— )

Catalog No. M33530 CAS No. 827031-83-4

Verubulin (MPC 6827) is a potent microtubule blocker with cytotoxic and potentially anticancer activity that disrupts newly formed blood vessels in xenografts, and can be used to image microtubules (MTs) using positron emission tomography (PET).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 32 Get Quote
10MG 44 Get Quote
25MG 65 Get Quote
50MG 90 Get Quote
100MG 133 Get Quote
500MG 327 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Verubulin
  • Note
    Research use only, not for human use.
  • Brief Description
    Verubulin (MPC 6827) is a potent microtubule blocker with cytotoxic and potentially anticancer activity that disrupts newly formed blood vessels in xenografts, and can be used to image microtubules (MTs) using positron emission tomography (PET).
  • Description
    Verubulin (MPC-6827) is a microtubule-disrupting agent with potent and broad-spectrum in vitro and in vivo cytotoxic activities, and acts as a promising candidate for the treatment of multiple cancer types.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Microtubule Associated
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    827031-83-4
  • Formula Weight
    279.34
  • Molecular Formula
    C17H17N3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (357.99 mM; Ultrasonic )
  • SMILES
    N=1C(=NC(=C2C=CC=CC12)N(C3=CC=C(OC)C=C3)C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kasibhatla S, et al. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps. Cancer Res. 2007 Jun 15;67(12):5865-71.?
molnova catalog
related products
  • GSK572A

    GSK572A is a novel and potent potent inhibitor of EchA6, which can be used to treat tuberculosis.

  • Phillygenin

    Phillyrin, (+)-Phillygenin, and (-)-phillygenin exert the strongest inhibitory activities on NO production with IC(5) values.

  • Tyroserleutide TFA

    Tyroserleutide TFA, isolated from the degradation products of porcine spleen, is a small molecular tripeptide which inhibits tumor growth both in vitro and in vivo.